Editorial & Opinion

T-Cell Engagers - Modern Immune-Based Therapies for Multiple Myeloma.

Bibliographic Details
Title: T-Cell Engagers - Modern Immune-Based Therapies for Multiple Myeloma.
Authors: Mailankody S; From the Myeloma and Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (S.M.); and the Division of Myeloma, Sylvester Comprehensive Cancer Center, University of Miami, Miami (O.L.)., Landgren O; From the Myeloma and Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (S.M.); and the Division of Myeloma, Sylvester Comprehensive Cancer Center, University of Miami, Miami (O.L.).
Source: The New England journal of medicine [N Engl J Med] 2022 Aug 11; Vol. 387 (6), pp. 558-561.
Publication Type: Editorial; Comment
Language: English
Journal Info: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
Imprint Name(s): Original Publication: Boston, Massachusetts Medical Society.
MeSH Terms: Immunotherapy*/methods , Immunotherapy*/trends , Multiple Myeloma*/drug therapy , Multiple Myeloma*/immunology , Multiple Myeloma*/therapy , T-Lymphocytes*/immunology, Humans ; Immunotherapy, Adoptive
Comments: Comment on: N Engl J Med. 2022 Aug 11;387(6):495-505. (PMID: 35661166)
Entry Date(s): Date Created: 20220810 Date Completed: 20220812 Latest Revision: 20220818
Update Code: 20221216
DOI: 10.1056/NEJMe2209692
PMID: 35947712
Database: MEDLINE
Description
ISSN:1533-4406
DOI:10.1056/NEJMe2209692